Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 06-Oct-2020
No. of pages: 119

According to this study, over the next five years the Hemophilia Gene Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Hemophilia Gene Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemophilia Gene Therapy market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Hemophilia Gene Therapy, covering the supply chain analysis, impact assessment to the Hemophilia Gene Therapy market size growth rate in several scenarios, and the measures to be undertaken by Hemophilia Gene Therapy companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Hemophilia A

- Hemophilia B

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Hemophilia A Gene Therapy

- Hemophilia B Gene Therapy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Spark Therapeutics

- Ultragenyx

- Sangamo Therapeutics

- Bioverativ

- Shire PLC

- Freeline Therapeutics

- BioMarin

- uniQure

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Hemophilia Gene Therapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Hemophilia Gene Therapy market by identifying its various subsegments.

- Focuses on the key global Hemophilia Gene Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Hemophilia Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Hemophilia Gene Therapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemophilia Gene Therapy Market Size 2015-2025
2.1.2 Hemophilia Gene Therapy Market Size CAGR by Region
2.2 Hemophilia Gene Therapy Segment by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia A
2.3 Hemophilia Gene Therapy Market Size by Type
2.3.1 Global Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Hemophilia Gene Therapy Market Size Growth Rate by Type (2015-2020)
2.4 Hemophilia Gene Therapy Segment by Application
2.4.1 Hemophilia A Gene Therapy
2.4.2 Hemophilia B Gene Therapy
2.5 Hemophilia Gene Therapy Market Size by Application
2.5.1 Global Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Hemophilia Gene Therapy Market Size Growth Rate by Application (2015-2020)

3 Global Hemophilia Gene Therapy by Players
3.1 Global Hemophilia Gene Therapy Market Size Market Share by Players
3.1.1 Global Hemophilia Gene Therapy Market Size by Players (2018-2020)
3.1.2 Global Hemophilia Gene Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Hemophilia Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hemophilia Gene Therapy by Regions
4.1 Hemophilia Gene Therapy Market Size by Regions
4.2 Americas Hemophilia Gene Therapy Market Size Growth
4.3 APAC Hemophilia Gene Therapy Market Size Growth
4.4 Europe Hemophilia Gene Therapy Market Size Growth
4.5 Middle East & Africa Hemophilia Gene Therapy Market Size Growth

5 Americas
5.1 Americas Hemophilia Gene Therapy Market Size by Countries
5.2 Americas Hemophilia Gene Therapy Market Size by Type
5.3 Americas Hemophilia Gene Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Hemophilia Gene Therapy Market Size by Regions
6.2 APAC Hemophilia Gene Therapy Market Size by Type
6.3 APAC Hemophilia Gene Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Hemophilia Gene Therapy by Countries
7.2 Europe Hemophilia Gene Therapy Market Size by Type
7.3 Europe Hemophilia Gene Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Hemophilia Gene Therapy by Countries
8.2 Middle East & Africa Hemophilia Gene Therapy Market Size by Type
8.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hemophilia Gene Therapy Market Forecast
10.1 Global Hemophilia Gene Therapy Market Size Forecast (2021-2025)
10.2 Global Hemophilia Gene Therapy Forecast by Regions
10.2.1 Global Hemophilia Gene Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Hemophilia Gene Therapy Forecast by Type
10.8 Global Hemophilia Gene Therapy Forecast by Application

11 Key Players Analysis
11.1 Spark Therapeutics
11.1.1 Company Details
11.1.2 Hemophilia Gene Therapy Product Offered
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Spark Therapeutics News
11.2 Ultragenyx
11.2.1 Company Details
11.2.2 Hemophilia Gene Therapy Product Offered
11.2.3 Ultragenyx Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Ultragenyx News
11.3 Sangamo Therapeutics
11.3.1 Company Details
11.3.2 Hemophilia Gene Therapy Product Offered
11.3.3 Sangamo Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Sangamo Therapeutics News
11.4 Bioverativ
11.4.1 Company Details
11.4.2 Hemophilia Gene Therapy Product Offered
11.4.3 Bioverativ Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bioverativ News
11.5 Shire PLC
11.5.1 Company Details
11.5.2 Hemophilia Gene Therapy Product Offered
11.5.3 Shire PLC Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Shire PLC News
11.6 Freeline Therapeutics
11.6.1 Company Details
11.6.2 Hemophilia Gene Therapy Product Offered
11.6.3 Freeline Therapeutics Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Freeline Therapeutics News
11.7 BioMarin
11.7.1 Company Details
11.7.2 Hemophilia Gene Therapy Product Offered
11.7.3 BioMarin Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 BioMarin News
11.8 uniQure
11.8.1 Company Details
11.8.2 Hemophilia Gene Therapy Product Offered
11.8.3 uniQure Hemophilia Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 uniQure News

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Hemophilia Gene Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Hemophilia A
Table 5. Major Players of Hemophilia B
Table 6. Hemophilia Gene Therapy Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Table 8. Global Hemophilia Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
Table 10. Global Hemophilia Gene Therapy Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Hemophilia Gene Therapy Revenue Market Share by Players (2018-2020)
Table 12. Global Hemophilia Gene Therapy Key Players Head office and Products Offered
Table 13. Hemophilia Gene Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hemophilia Gene Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Hemophilia Gene Therapy Market Size Market Share by Regions 2015-2020
Table 18. Americas Hemophilia Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Hemophilia Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 20. Americas Hemophilia Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Table 22. Americas Hemophilia Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
Table 24. APAC Hemophilia Gene Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Hemophilia Gene Therapy Market Size Market Share by Regions (2015-2020)
Table 26. APAC Hemophilia Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Table 28. APAC Hemophilia Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
Table 30. Europe Hemophilia Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Hemophilia Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 32. Europe Hemophilia Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Table 34. Europe Hemophilia Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Hemophilia Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Hemophilia Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Hemophilia Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Hemophilia Gene Therapy
Table 43. Key Application and Potential Industries of Hemophilia Gene Therapy
Table 44. Key Challenges of Hemophilia Gene Therapy
Table 45. Key Trends of Hemophilia Gene Therapy
Table 46. Global Hemophilia Gene Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Regions
Table 48. Global Hemophilia Gene Therapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Hemophilia Gene Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Hemophilia Gene Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 52. Spark Therapeutics Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 53. Spark Therapeutics Hemophilia Gene Therapy Product Offered
Table 54. Spark Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 55. Spark Therapeutics Main Business
Table 56. Spark Therapeutics Latest Developments
Table 57. Ultragenyx Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 58. Ultragenyx Hemophilia Gene Therapy Product Offered
Table 59. Ultragenyx Main Business
Table 60. Ultragenyx Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 61. Ultragenyx Latest Developments
Table 62. Sangamo Therapeutics Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 63. Sangamo Therapeutics Hemophilia Gene Therapy Product Offered
Table 64. Sangamo Therapeutics Main Business
Table 65. Sangamo Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 66. Sangamo Therapeutics Latest Developments
Table 67. Bioverativ Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 68. Bioverativ Hemophilia Gene Therapy Product Offered
Table 69. Bioverativ Main Business
Table 70. Bioverativ Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 71. Bioverativ Latest Developments
Table 72. Shire PLC Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 73. Shire PLC Hemophilia Gene Therapy Product Offered
Table 74. Shire PLC Main Business
Table 75. Shire PLC Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 76. Shire PLC Latest Developments
Table 77. Freeline Therapeutics Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 78. Freeline Therapeutics Hemophilia Gene Therapy Product Offered
Table 79. Freeline Therapeutics Main Business
Table 80. Freeline Therapeutics Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 81. Freeline Therapeutics Latest Developments
Table 82. BioMarin Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 83. BioMarin Hemophilia Gene Therapy Product Offered
Table 84. BioMarin Main Business
Table 85. BioMarin Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 86. BioMarin Latest Developments
Table 87. uniQure Details, Company Total Revenue (in $ million), Head Office, Hemophilia Gene Therapy Major Market Areas and Its Competitors
Table 88. uniQure Hemophilia Gene Therapy Product Offered
Table 89. uniQure Main Business
Table 90. uniQure Hemophilia Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 91. uniQure Latest Developments

List of Figures

Figure 1. Hemophilia Gene Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Hemophilia Gene Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Hemophilia Gene Therapy Market Size Market Share by Type (2015-2020)
Figure 5. Global Hemophilia A Market Size Growth Rate
Figure 6. Global Hemophilia B Market Size Growth Rate
Figure 7. Hemophilia Gene Therapy in Hemophilia A Gene Therapy
Figure 8. Global Hemophilia Gene Therapy Market: Hemophilia A Gene Therapy (2015-2020) ($ Millions)
Figure 9. Hemophilia Gene Therapy in Hemophilia B Gene Therapy
Figure 10. Global Hemophilia Gene Therapy Market: Hemophilia B Gene Therapy (2015-2020) ($ Millions)
Figure 11. Global Hemophilia Gene Therapy Market Size Market Share by Application in 2019
Figure 12. Global Hemophilia Gene Therapy Market Size Market Share by Regions 2015-2020
Figure 13. Americas Hemophilia Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 14. APAC Hemophilia Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 15. Europe Hemophilia Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 16. Middle East & Africa Hemophilia Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 17. Americas Hemophilia Gene Therapy Market Size Market Share by Countries in 2019
Figure 18. Americas Hemophilia Gene Therapy Market Size Market Share by Type in 2019
Figure 19. Americas Hemophilia Gene Therapy Market Size Market Share by Application in 2019
Figure 20. United States Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 21. Canada Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 22. Mexico Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 23. APAC Hemophilia Gene Therapy Market Size Market Share by Regions in 2019
Figure 24. APAC Hemophilia Gene Therapy Market Size Market Share by Type in 2019
Figure 25. APAC Hemophilia Gene Therapy Market Size Market Share by Application in 2019
Figure 26. China Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 27. Japan Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 28. Korea Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 29. Southeast Asia Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 30. India Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 31. Australia Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 32. Europe Hemophilia Gene Therapy Market Size Market Share by Countries in 2019
Figure 33. Europe Hemophilia Gene Therapy Market Size Market Share by Type in 2019
Figure 34. Europe Hemophilia Gene Therapy Market Size Market Share by Application in 2019
Figure 35. Germany Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 36. France Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. UK Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 38. Italy Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 39. Russia Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 40. Spain Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Countries in 2019
Figure 42. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Type in 2019
Figure 43. Middle East & Africa Hemophilia Gene Therapy Market Size Market Share by Application in 2019
Figure 44. Egypt Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 45. South Africa Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. Israel Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 47. Turkey Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 48. GCC Countries Hemophilia Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 49. Global Hemophilia Gene Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 50. Americas Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 51. APAC Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 52. Europe Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 53. Middle East & Africa Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 54. United States Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 55. Canada Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 56. Mexico Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 57. Brazil Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 58. China Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 59. Japan Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 60. Korea Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 61. Southeast Asia Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 62. India Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 63. Australia Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 64. Germany Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 65. France Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 66. UK Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Italy Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 68. Russia Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 69. Spain Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Egypt Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 71. South Africa Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 72. Israel Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 73. Turkey Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 74. GCC Countries Hemophilia Gene Therapy Market Size 2021-2025 ($ Millions)
  • Global Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period. The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......
  • Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
    Published: 01-Jan-2024        Price: US 2450 Onwards        Pages: 260
    Executive Summary Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......
  • Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 88
    According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......
  • Global Gene Expression Analysis Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 102
    Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 125
    Market Overview of Global Gene Expression Analysis market: According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Animal Genetics Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics. Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......
  • Global Animal Genetics Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 105
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Gene Therapy Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 450
    Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs